Biotech · Private company
DisperSol Technologies, LLC
Track this companyFree. Adds DisperSol Technologies, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- DST-0509Phase 2 · Thalassemia MajorClinicalTrials.gov · fetched Nov 12, 2026
- ExjadePhase 2 · Thalassemia MajorClinicalTrials.gov · fetched Nov 12, 2026
- JadenuPhase 2 · Thalassemia MajorClinicalTrials.gov · fetched Nov 12, 2026
- Abiraterone AcetatePhase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- DST-2970 (Abiraterone)Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Prednisone 5Mg TabPhase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- PK and Dose Escalation and Expansion Study of DST-2970PHASE1 · TERMINATED · started Jan 31, 2020ClinicalTrials.gov NCT04291664 · fetched Nov 12, 2026
- Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to ChelationPHASE2 · COMPLETED · started Aug 20, 2019ClinicalTrials.gov NCT03637556 · fetched Nov 12, 2026